Literature DB >> 26427380

Comparative analysis of transcriptional profiles of retinoic-acid-induced gene I-like receptors and interferons in seven tissues from ducks infected with avian Tembusu virus.

Guanghua Fu1, Cuiteng Chen2, Yu Huang3, Longfei Cheng4, Qiuling Fu5, Chunhe Wan6, Shaohua Shi7, Hongmei Chen8, Wei Liu9.   

Abstract

Avian Tembusu virus (ATV), an emerging virus that mainly infects laying and breeding ducks in China, has caused severe economic loss in duck industry. However, there have been no reports about host innate immune responses during ATV infection and its correlation with clinical signs or pathology. To identify the roles of these immune factors in the innate host response to ATV infection, quantitative real-time PCR (qPCR) was used to analyze the transcriptional profiles on the genes encoding two retinoic-acid-induced gene I (RIG-I)-like receptors (RLRs) and two interferons (INF-α and INF-γ) in seven tissues of an ATV-infected shelduck. After infection with ATV, both RLR genes were significantly upregulated (P < 0.05) in all seven tissues. The peak expression levels of the two RLR genes were observed at 24 hours postinfection (hpi) and were higher in non-lymphoid tissues (liver, lung, kidney, and ovary) than in lymphoid tissues (thymus, spleen and bursa). Although the transcription levels of both IFN genes were also upregulated, they showed different time-dependent expression patterns compared with those of the RLR genes. In addition, the highest mRNA expression of the two IFN genes was observed in the ovary at 6 hpi. This observation suggests that the ovary is the primary target tissue in ATV infection and explains the clinical characteristics of the primary pathological changes in the ovaries of ATV-infected ducks. Our results, for the first time, elucidate the differential and coordinated expression profiles of two RLRs and two IFNs in an ATV-infected shelduck.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26427380     DOI: 10.1007/s00705-015-2621-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Goose Mx and OASL Play Vital Roles in the Antiviral Effects of Type I, II, and III Interferon against Newly Emerging Avian Flavivirus.

Authors:  Shun Chen; Wei Zhang; Zhen Wu; Jinyue Zhang; Mingshu Wang; Renyong Jia; Dekang Zhu; Mafeng Liu; Kunfeng Sun; Qiao Yang; Ying Wu; Xiaoyue Chen; Anchun Cheng
Journal:  Front Immunol       Date:  2017-08-23       Impact factor: 7.561

2.  Avian Interferon-Inducible Transmembrane Protein Family Effectively Restricts Avian Tembusu Virus Infection.

Authors:  Shilong Chen; Long Wang; Jieying Chen; Lanlan Zhang; Song Wang; Mohsan U Goraya; Xiaojuan Chi; Yang Na; Wenhan Shao; Zhou Yang; Xiancheng Zeng; Shaoying Chen; Ji-Long Chen
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

3.  Comparative Transcriptomic Analysis of Immune-Related Gene Expression in Duck Embryo Fibroblasts Following Duck Tembusu Virus Infection.

Authors:  Guanliu Yu; Yun Lin; Yi Tang; Youxiang Diao
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

4.  Duck LGP2 Downregulates RIG-I Signaling Pathway-Mediated Innate Immunity Against Tembusu Virus.

Authors:  Tianxu Li; Yanyan Ren; Tingting Zhang; Xinyu Zhai; Xiuyuan Wang; Jinchao Wang; Bin Xing; Runchun Miao; Ning Li; Liangmeng Wei
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

5.  Avian Tembusu virus infection effectively triggers host innate immune response through MDA5 and TLR3-dependent signaling pathways.

Authors:  Shilong Chen; Guifeng Luo; Zhou Yang; Shuncheng Lin; Shaoying Chen; Song Wang; Mohsan Ullah Goraya; Xiaojuan Chi; Xiancheng Zeng; Ji-Long Chen
Journal:  Vet Res       Date:  2016-07-22       Impact factor: 3.683

6.  Evolution of Tembusu Virus in Ducks, Chickens, Geese, Sparrows, and Mosquitoes in Northern China.

Authors:  Guanliu Yu; Yun Lin; Yi Tang; Youxiang Diao
Journal:  Viruses       Date:  2018-09-10       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.